Pharmaceutical Intellectual Property and Competition

In-Depth: Pharmaceutical Intellectual Property and Competition (formerly The Pharmaceutical Intellectual Property and Competition Law Review) provides a practical overview of pharmaceutical intellectual property issues, including patent linkage and exclusivities, and related competition concerns. With a focus on recent developments, it is a useful tool for managing global risks in this area – analysing the key elements of the relevant legal and regulatory regimes across major jurisdictions worldwide.


  • Editor's Preface


  • Australia Jones Day
  • Brazil Pinheiro Neto Advogados
  • China Haiwen & Partners
  • France August Debouzy
  • Germany Kather Augenstein Rechtsanwälte PartGmbB
  • India LexOrbis
  • Japan Nishimura & Asahi
  • South Korea Lee & Ko
  • Spain Uría Menéndez
  • Taiwan Lee Tsai & Partners
  • United Kingdom Bird & Bird LLP
  • USA Arnold & Porter